Eric Soller | Vice President Of Corporate Development And Strategy
BlueRock Therapeutics

Eric Soller, Vice President Of Corporate Development And Strategy, BlueRock Therapeutics

Eric Soller, Ph.D., is BlueRock’s VP of corporate development and strategy. Dr. Soller led the launch of BlueRock as an entrepreneur-in-residence at Versant Ventures, a leading healthcare investment firm committed to helping exceptional entrepreneurs build the next generation of great healthcare companies. Prior to joining Versant in 2016, Dr. Soller was a junior partner in McKinsey & Company’s New York office and a leader in the firm’s healthcare and corporate finance practices. He has advised leading biopharma companies on a range of strategic and operational issues across marketing, sales, R&D, and business and corporate development. He holds a B.S. in mechanical engineering with minors in applied biology and biomedical engineering from the Rose-Hulman Institute of Technology, and a Ph.D. in mechanical engineering with a biomedical focus from the Massachusetts Institute of Technology, where his scientific work centered on induced organ regeneration.


Conference Day 2: Friday 17th May 2019 @ 11:05

The changing paradigm for cell therapy

  • How we access partnerships through technology, process development and manufacturing
  • Shifts challenges and opportunities
last published: 17/Jan/19 16:45 GMT

back to speakers



Erica Baeta
+44 (0)207 092 1152


Jessica Robinson
t/ +44 (0)207 092 1150


Issa Mauthoor
+44 (0)207 092 1257